Cargando…

Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations

With about 0.4–0.5 million COVID cases diagnosed every single day in a row over the past three weeks back in May 2021, India was at the epicenter of the global viral rampage. The catastrophe of this crisis was unprecedented, pushing the health care system to its breaking point. Although significant...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhar, Ruby, Pethusamy, Karthikeyan, Jee, Babban, Karmakar, Subhradip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568696/
https://www.ncbi.nlm.nih.gov/pubmed/34754251
http://dx.doi.org/10.2147/RMHP.S320880
_version_ 1784594487856594944
author Dhar, Ruby
Pethusamy, Karthikeyan
Jee, Babban
Karmakar, Subhradip
author_facet Dhar, Ruby
Pethusamy, Karthikeyan
Jee, Babban
Karmakar, Subhradip
author_sort Dhar, Ruby
collection PubMed
description With about 0.4–0.5 million COVID cases diagnosed every single day in a row over the past three weeks back in May 2021, India was at the epicenter of the global viral rampage. The catastrophe of this crisis was unprecedented, pushing the health care system to its breaking point. Although significant progress has been made in identifying these highly transmissible variants, what is somewhat lacking is the competence to exploit this information for risk mitigation and effective disease management through an integrated nationwide coordinated approach. With a positivity rate of 15–20% (April–May 2021) and the healthcare system pushed to its limit, accompanied by increased mortality, the situation was rather grim then. Though the central command scrambled all its resources and logistics to streamline the supply chain, the efforts were insufficient in response to the ongoing crisis due to a disproportionate rise in the case. We examined the current scenario emerging from this 2nd COVID wave and identified the possible lacunae. We also suggested few recommendations that may be adopted to avoid similar failures in the future.
format Online
Article
Text
id pubmed-8568696
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85686962021-11-08 Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations Dhar, Ruby Pethusamy, Karthikeyan Jee, Babban Karmakar, Subhradip Risk Manag Healthc Policy Review With about 0.4–0.5 million COVID cases diagnosed every single day in a row over the past three weeks back in May 2021, India was at the epicenter of the global viral rampage. The catastrophe of this crisis was unprecedented, pushing the health care system to its breaking point. Although significant progress has been made in identifying these highly transmissible variants, what is somewhat lacking is the competence to exploit this information for risk mitigation and effective disease management through an integrated nationwide coordinated approach. With a positivity rate of 15–20% (April–May 2021) and the healthcare system pushed to its limit, accompanied by increased mortality, the situation was rather grim then. Though the central command scrambled all its resources and logistics to streamline the supply chain, the efforts were insufficient in response to the ongoing crisis due to a disproportionate rise in the case. We examined the current scenario emerging from this 2nd COVID wave and identified the possible lacunae. We also suggested few recommendations that may be adopted to avoid similar failures in the future. Dove 2021-10-28 /pmc/articles/PMC8568696/ /pubmed/34754251 http://dx.doi.org/10.2147/RMHP.S320880 Text en © 2021 Dhar et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Dhar, Ruby
Pethusamy, Karthikeyan
Jee, Babban
Karmakar, Subhradip
Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations
title Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations
title_full Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations
title_fullStr Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations
title_full_unstemmed Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations
title_short Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations
title_sort fault lines in india’s covid-19 management: lessons learned and future recommendations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568696/
https://www.ncbi.nlm.nih.gov/pubmed/34754251
http://dx.doi.org/10.2147/RMHP.S320880
work_keys_str_mv AT dharruby faultlinesinindiascovid19managementlessonslearnedandfuturerecommendations
AT pethusamykarthikeyan faultlinesinindiascovid19managementlessonslearnedandfuturerecommendations
AT jeebabban faultlinesinindiascovid19managementlessonslearnedandfuturerecommendations
AT karmakarsubhradip faultlinesinindiascovid19managementlessonslearnedandfuturerecommendations